Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.64 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.61 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.60 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 3/20 | 0.55 |
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13336948 | 1.00 | GLP1R (0.64) | GLP1RNOD1LPAR3LPAR1FAAH | |
| SCHEMBL4828756 | 1.00 | GLP1R (0.64) | GLP1RNOD1LPAR3LPAR1FAAH | |
| SCHEMBL15085165 | 0.91 | GLP1R (0.64) | GLP1RNOD1LPAR3LPAR1CASP2 | |
| SCHEMBL14642513 | 0.90 | GLP1R (0.63) | GLP1RNOD1LPAR3LPAR1CASP2 | |
| SCHEMBL6931475 | 0.90 | NOD1 (0.60) | GLP1RNOD1LPAR3LPAR1 | |
| SCHEMBL20542805 | 0.89 | LPAR3 (0.65) | GLP1RNOD1LPAR3LPAR1FAAH | |
| SCHEMBL20542804 | 0.89 | LPAR3 (0.65) | GLP1RNOD1LPAR3LPAR1FAAH | |
| SCHEMBL18889580 | 0.89 | GLP1R (0.62) | GLP1RNOD1LPAR3LPAR1CASP2 | |
| SCHEMBL18889446 | 0.89 | GLP1R (0.62) | GLP1RNOD1LPAR3LPAR1CASP2 | |
| SCHEMBL9517290 | 0.88 | GLP1R (0.61) | GLP1RNOD1LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210353511-A1 | GEL STICK COMPOSITIONS | CALUMET SPECIALTY PRODUCTS PARTNERS L P (US) | 2021-11-18 | — | — | US | disclosed |
| US-20170037219-A1 | PHOTOCURABLE RESIN COMPOSITION, IMAGE DISPLAY DEVICE, AND METHOD FOR PRODUCING SAME | HITACHI CHEMICAL CO LTD (JP) | 2017-02-09 | — | — | US | disclosed |
| US-20160312085-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL CO LTD (JP) | 2016-10-27 | — | — | US | disclosed |
| US-9394457-B2 | Photo curable resin composition, imaging display device and production method thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150368499-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL COMPANY, LTD. | 2015-12-24 | — | — | US | disclosed |
| US-9150706-B2 | Photo curable resin composition, imaging display device and production method thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150050509-A1 | PHOTOCURABLE RESIN COMPOSITION, IMAGE DISPLAY DEVICE, AND METHOD FOR PRODUCING SAME | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2015-02-19 | — | — | US | disclosed |
| US-20140284056-A1 | N-ACYL AMINO ACID ALKYLAMIDE IN OIL-BASED PARTICULATE CARRIER FLUIDS FOR WELL TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-8765309-B2 | Electrochemical device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20130286604-A1 | PHOTO CURABLE RESIN COMPOSITION, IMAGING DISPLAY DEVICE AND PRODUCTION METHOD THEREOF | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-8360565-B2 | Material for an inkjet ink composition and inkjet ink composition | RICOH COMPANY, LIMITED (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110143211-A1 | ELECTROCHEMICAL DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20110060100-A1 | MATERIAL FOR AN INKJET INK COMPOSITION AND INKJET INK COMPOSITION | RICOH COMPANY LIMITED (JP) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210353511-A1 | GEL STICK COMPOSITIONS | CAT, EBPL, GPX4 | GLP1R 4545/4885NOD1 3809/4885LPAR3 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.